Pfizer Stock News

Pfizer''s vaccine for kids between 5 and 11 will be in our province by the end of this week. However, those shots won''t go into arms until December 2nd

By Sue TiffinHealth Canada has approved Pfizer-BioNTechs COVID-19 vaccine for children aged five to 11.In a much anticipated announcement last Friday, Pfizers Comirnaty became the first COVID-19 vaccine authorized in Canada for a younger age group meaning it will soon be available to 11,115 children across the Haliburton, Kawartha, Pine Ridge district area 844 [] The post Vaccines approved for youth 5 to 11 appeared first on Haliburton Echo .

Another week, another Corona news story in Germany so absurd that it would be laughable if it werent so serious. Yes, in a week in which we see exponential growth in Coronavirus case numbers and over 1,000 mainly unvaccinated people are set to die of Covid, our caretaker health minister gets caught up in a []

Complete study of the global Hospital Acquired Infection Control market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding

CARLSBAD, Calif., Nov. 24, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that Pfizer has provided an update on the Phase 2b study of vupanorsen, formerly IONIS-ANGPTL3-LRx. Vupanorsen is an investigational antisense therapy being developed for indications

Leading drug-making company AstraZenecas CEO Pascal Soriot said that the corporations vaccine can provide longer protection, and effectiveness for older people against COVID-19 more than other mRNA-technology-based vaccines such as Pfizer, and Moderna, Politico reported on Tuesday. Hence, the UK hasnt suffered from a high surge in infections, and hospitalizations such as the other European []

Cladribine and Pentostatin are anticancer drugs usually used to treat hairy cell leukemia. There is currently no curative treatment for the hairy cell leukemia variant. The results of treatment with cladribine or pentostatin are rather poor. An analysis of 19

Global Ovarian cancer drug report deals with the new business challenges and investment research on the market which includes market attributes, industry structure, and competitive scenario, the problems, desire concepts, together with business strategies and market effectiveness. This is the

Promit Mukherjee JOHANNESBURG - South Africa has asked Johnson & Johnson and Pfizer to delay delivery of COVID-19 vaccines because it now has too much stock, health ministry officials said, as vaccine hesitancy slows an inoculation campaign. About 35% of South Africans are fully vaccinated, higher than in most other African nations, but half the government''s year-end target. It has averaged 106,000 doses a day in the past 15 days in a nation of 60 million people. Earlier this year the programme was slowed by insufficient doses. Now deliveries have been delayed due to oversupply, making the country an outlier in the continent where most are still starved of vaccines. Nicholas Crisp, deputy director-general of the Health Department, told Reuters that South Africa had 16.8 million doses in stock and said deliveries had been deferred. "We have 158 days'' stock in the country at current use," a spokesman for the Health Ministry said. "We have deferred some deliveries." They did not say when deliveries would now take place.

Publisher’s Hormonal Contraceptives market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights

South Africa has asked Johnson & Johnson and Pfizer to delay delivery of Covid-19 vaccines because it now has too much stock.

South Africa has asked Johnson & Johnson and Pfizer to delay delivery of COVID-19 vaccines because it now has too much stock, health ministry officials said, as vaccine hesitancy slows an inoculation campaign.

Thai Cabinet on Tuesday approved another purchase deal for 30 million doses of the Pfizer-BioNTech COVID-19 vaccine, including an option for pediatric doses. Deliveries for these extra doses are expected to start in the first quarter of next year. The Cabinet in its weekly meeting endorsed a proposal to purchase 30 million more doses of []

San Diego, CA - November 03: On Wednesday, Nov. 3, 2021 in San Diego, CA., Monica Strickland from La Jolla celebrated with a thumbs up with her daughter, Madeleine Stricklanbd, 11 after receiving Pfizer vaccine. As for Liam Strickland, 6 he was not too happy about being inoculated. (Nelvin C. Cepeda - The San Diego Union-Tribune)